← Open Payments lookup

JUSTIN MAHR: Open Payments

NPI 1255981841 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$933 in 22 payments from 6 companies in 2025. Trend: 2023 $601 · 2024 $881 · 2025 $933

Food & beverage: $933
CompanyPaymentsAmount
Gilead Sciences, Inc.8$272
Madrigal Pharmaceuticals5$270
Ipsen Biopharmaceuticals, Inc3$168
Intercept Pharmaceuticals, Inc.1$97
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$96
Takeda Pharmaceuticals U.S.A., Inc.1$30

Products named: REZDIFFRA, Livdelzi, IQIRVO, OCALIVA, XIFAXAN, LIVTENCITY.

Industry payments across DE — which companies pay providers there.